YINOW ELECTRIC
837046
SUGON DATA ENERGY
872808
Dark Horse Technology Group
300688
Shenzhen L&A Design
300949
Shanghai Kaytune Industrial
301001
CN Stock MarketDetailed Quotes
600436 Zhangzhou Pientzehuang Pharmaceutical
- 221.08
- +2.05+0.94%
Market Closed Dec 19 15:00 CST
133.38BMarket Cap43.32P/E (TTM)
221.20High217.17Low18.88KlotVolume217.77Open219.03Pre Close415.11MTurnover0.31%Turnover Ratio47.68P/E (Static)603.32MShares283.1952wk High9.51P/B133.38BFloat Cap177.2252wk Low240.93Limit Up603.32MShs Float485.95Historical High197.13Limit Down1.84%Amplitude-7.33Historical Low3.47Dividend TTM219.82Avg Price8.12KlotAsk1.57%Div YieldTTM100Lot Size8.97KlotBid
Zhangzhou Pientzehuang Pharmaceutical Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Money funds | 24.17%3.27B | 216.82%8.92B | -20.05%2.37B | -53.58%1.16B | 8.98%2.63B | 3.13%2.82B | -60.38%2.97B | -64.82%2.5B | -64.08%2.42B | -53.13%2.73B |
| Transactional financial assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --5.81K | -28.39%16.41K |
| Notes receivable and accounts receivable | 10.05%825.36M | 12.60%854.5M | 24.41%947.26M | 18.42%968.48M | -3.82%750.01M | -2.47%758.89M | 7.46%761.39M | 23.12%817.86M | 18.67%779.8M | 18.04%778.09M |
| -Notes receivable | -35.92%33.93M | -24.28%44.93M | 17.42%58.18M | -22.79%56.73M | 31.58%52.94M | 33.07%59.34M | 50.37%49.55M | 41.19%73.48M | 18.71%40.24M | 66.14%44.59M |
| -Accounts receivable | 13.54%791.43M | 15.73%809.57M | 24.90%889.08M | 22.48%911.75M | -5.75%697.07M | -4.63%699.55M | 5.37%711.85M | 21.58%744.38M | 18.67%739.57M | 16.00%733.5M |
| Other receivables (including interest and dividends) | -21.95%68.28M | -21.72%73.33M | -34.77%65.49M | -45.45%56.66M | -35.42%87.48M | -30.55%93.68M | -19.17%100.4M | -12.62%103.86M | 48.75%135.46M | 61.06%134.89M |
| -Dividend receivable | 0.00%12M | 12.59%20.72M | ---- | ---- | -9.09%12M | 38.30%18.4M | ---- | ---- | --13.2M | 90.52%13.3M |
| -Other receivable | ---- | -30.11%52.61M | ---- | ---- | ---- | -38.08%75.28M | ---- | -12.62%103.86M | ---- | 58.38%121.58M |
| Advance payment | 26.79%233.92M | -29.64%268.96M | 126.52%353.39M | 1.57%340.43M | -30.63%184.49M | 89.75%382.29M | 45.89%156.01M | 74.56%335.18M | 40.57%265.94M | 47.94%201.47M |
| Inventories | 64.13%4.57B | 77.58%4.54B | 43.23%3.88B | 28.57%3.38B | 18.46%2.78B | 10.55%2.56B | 8.47%2.71B | 7.81%2.63B | 5.66%2.35B | 5.17%2.31B |
| Receivable financing | -35.38%42.65M | -42.47%58.85M | 11.98%125.29M | 26.75%52.77M | 21.67%66M | 173.33%102.28M | 635.62%111.89M | 362.75%41.63M | 1.61%54.24M | 48.03%37.42M |
| Other current assets | -10.38%6.84B | -94.38%409.62M | 35.50%8.58B | 45.56%9.14B | 33.71%7.63B | 32.18%7.28B | 6,418.86%6.33B | 5,820.82%6.28B | 5,709.04%5.71B | 5,970.82%5.51B |
| Total current assets | 12.11%15.84B | 8.10%15.13B | 24.24%16.32B | 18.85%15.1B | 20.73%14.13B | 19.54%13.99B | 18.94%13.14B | 19.48%12.7B | 16.62%11.71B | 29.76%11.7B |
| Non Current assets | ||||||||||
| Other equity investment | 8.65%439.13M | -11.54%342.62M | -9.05%356.21M | 0.38%377.1M | 13.20%404.19M | 3.01%387.33M | -1.34%391.66M | -20.18%375.68M | -24.16%357.07M | -20.18%376.03M |
| Other non-current financial assets | 36.80%46.1M | 36.86%46.12M | -7.88%46.17M | 14.41%61.32M | -44.83%33.7M | -45.41%33.7M | -18.54%50.12M | -13.12%53.6M | -2.05%61.08M | 5.57%61.73M |
| Investment real estate | -39.95%8.66M | -38.31%9.34M | -27.09%11.99M | -41.03%13.64M | -36.83%14.42M | -37.19%15.13M | -30.37%16.44M | -12.48%23.13M | -16.11%22.83M | -23.48%24.09M |
| Long-term equity investment | 20.08%271.02M | -21.95%173.83M | -20.99%194.87M | -20.81%193.55M | -6.36%225.7M | -10.36%222.71M | -12.27%246.65M | -8.64%244.42M | -29.76%241.04M | -26.59%248.46M |
| Fixed assets | ---- | 22.36%320.43M | ---- | ---- | ---- | 0.28%261.87M | ---- | -1.17%260.89M | ---- | 1.85%261.14M |
| Fixed assets liquidation | ---- | ---- | ---- | ---- | ---- | -96.73%1.29K | ---- | -98.37%1.24K | ---- | --39.5K |
| Constru in process | ---- | 75.84%186.51M | ---- | ---- | ---- | 161.79%106.07M | ---- | 306.79%60.78M | ---- | 1,428.99%40.52M |
| Productive biological assets | 4.52%12.78M | 3.91%12.45M | 4.09%12.27M | 5.44%12.22M | -5.95%12.22M | -6.31%11.99M | -5.53%11.78M | -6.69%11.59M | -1.84%13M | -6.21%12.79M |
| Intangible assets | -10.40%276.83M | -9.78%279.08M | -7.10%288.4M | -8.86%291.09M | 8.38%308.94M | 6.54%309.32M | 47.14%310.45M | 44.54%319.37M | 20.61%285.06M | 20.91%290.32M |
| Long deferred expense | -36.17%24.6M | -42.77%25.46M | -28.73%27.5M | -20.35%29.99M | 4.92%38.54M | 10.70%44.49M | -0.97%38.58M | -14.78%37.65M | -22.92%36.73M | -14.20%40.2M |
| Deferred tax assets | 6.37%200.72M | 6.46%190.25M | 13.36%201.51M | 11.99%187.31M | 51.60%188.71M | 36.73%178.71M | 12.34%177.76M | 0.17%167.26M | -2.34%124.48M | 23.37%130.71M |
| Usufruct assets | 9.97%131.56M | 1.73%127.59M | 5.89%135.97M | 0.08%132.47M | -5.27%119.62M | -0.11%125.42M | 22.24%128.41M | 21.66%132.36M | 12.80%126.28M | 6.75%125.56M |
| Other non current assets | -17.20%178.61M | -5.02%207.39M | 1.77%217.26M | -0.26%211.72M | -5.24%215.72M | -4.66%218.36M | -15.33%213.49M | -7.34%212.28M | 1.22%227.64M | -2.86%229.03M |
| Adjustment items of non current assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---0.01 |
| Total non current assets | 9.21%2.14B | 0.31%1.92B | 2.18%1.97B | 4.29%1.98B | 8.57%1.96B | 4.05%1.92B | 5.59%1.93B | 0.60%1.9B | -6.86%1.81B | -4.06%1.84B |
| Total assets | 11.75%17.99B | 7.17%17.05B | 21.41%18.29B | 16.96%17.08B | 19.10%16.1B | 17.44%15.91B | 17.05%15.07B | 16.63%14.6B | 12.82%13.51B | 23.83%13.55B |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Short term loan | 20.80%983.19M | 14.38%1.02B | 19.48%1.08B | 1.95%989.93M | 1.45%813.87M | 12.41%892.72M | 26.48%904.03M | 25.16%970.96M | 15.90%802.22M | 14.99%794.14M |
| Notes payable and accounts payable | -4.12%417.9M | 9.54%501.93M | 83.97%767.54M | 44.29%673.15M | 8.49%435.85M | 25.57%458.19M | 41.18%417.22M | 20.34%466.52M | 25.26%401.74M | 29.42%364.9M |
| -Notes payable | -93.45%4.85M | -71.28%31.03M | 73.60%197.45M | 61.47%167.29M | -3.45%74.03M | 92.60%108.06M | 82.05%113.74M | 58.90%103.6M | 13.93%76.67M | 1,218.18%56.11M |
| -Accounts payable | 14.16%413.05M | 34.49%470.89M | 87.85%570.09M | 39.39%505.86M | 11.31%361.82M | 13.39%350.13M | 30.22%303.48M | 12.55%362.92M | 28.27%325.06M | 11.20%308.79M |
| Contract liabilities | -22.69%65.83M | -30.32%86.79M | -32.68%81.27M | -49.40%237.1M | 7.59%85.15M | 57.76%124.56M | 3.59%120.72M | 43.49%468.57M | 31.80%79.14M | -29.22%78.95M |
| Advance receipts | -81.65%2.86M | 215.55%9.56M | 44.78%11.96M | -61.97%3.58M | 17.58%15.6M | -64.83%3.03M | -15.55%8.26M | 57.81%9.42M | -61.51%13.26M | -20.99%8.62M |
| Salaries payable | -5.77%151.5M | 1.04%131.83M | 4.53%140.41M | 13.35%150.15M | 77.62%160.77M | 2.88%130.46M | 21.09%134.33M | 30.07%132.46M | -23.01%90.51M | 12.90%126.81M |
| Taxs payable | -9.42%270.18M | -15.15%200.48M | 48.84%315.81M | 60.41%172.98M | 40.36%298.27M | 52.13%236.27M | -10.35%212.17M | -20.75%107.83M | -30.33%212.5M | -16.68%155.32M |
| Other payable (including interest and dividends) | 179.78%1.17B | -50.06%540.12M | 99.18%664.5M | 120.06%595.47M | 42.14%418.76M | -0.67%1.08B | -11.64%333.62M | -22.38%270.6M | -25.34%294.62M | 166.56%1.09B |
| -Dividend payable | 11,731.81%693.81M | -99.87%981.3K | 7.31%7.45M | 9.93%7.63M | 0.00%5.86M | 3.28%760.01M | 18.41%6.94M | 18.41%6.94M | 0.00%5.86M | 12,449.12%735.88M |
| -Other payable | ---- | 67.68%539.13M | ---- | ---- | ---- | -8.90%321.53M | ---- | -23.08%263.66M | ---- | -12.34%352.95M |
| Non current liabilities due within one year | 0.32%28.1M | -7.47%27.56M | 0.71%29.76M | 15.46%33.73M | 36.58%28.01M | 33.59%29.79M | 70.94%29.55M | 28.38%29.21M | --20.51M | --22.3M |
| Other current liabilities | -15.55%5.33M | -44.55%7.77M | -10.45%6.78M | -50.51%27.02M | -1.00%6.31M | 109.84%14.01M | 83.79%7.57M | 71.75%54.59M | -52.68%6.38M | -38.99%6.68M |
| Total current liabilities | 36.86%3.1B | -14.93%2.53B | 42.94%3.1B | 14.86%2.88B | 17.79%2.26B | 12.24%2.97B | 15.10%2.17B | 17.46%2.51B | -0.88%1.92B | 45.96%2.65B |
| Current liabilities | ||||||||||
| Long term loan | 73.86%51.42M | 154.90%49.17M | --48.08M | --35.44M | --29.58M | --19.29M | ---- | ---- | ---- | ---- |
| Long term salaries pay | -1.58%33.99M | -0.47%34.78M | -0.46%34.59M | 2.20%35.04M | 7.21%34.54M | 6.41%34.94M | 6.52%34.75M | 6.37%34.29M | 12.11%32.22M | 12.89%32.84M |
| Estimate liabilities | ---- | ---- | --6.61M | --12M | ---- | ---- | ---- | ---- | ---- | ---- |
| Deferred tax liabilities | -48.80%28.8M | -54.45%22.49M | -56.81%29.03M | -50.86%30.02M | 172.28%56.24M | 73.96%49.38M | 61.17%67.22M | -18.02%61.09M | -57.92%20.66M | -37.19%28.38M |
| Long term deferred income | 59.04%27.18M | 24.31%21.94M | 10.88%18.41M | 3.87%17.67M | -9.40%17.09M | -10.65%17.65M | -17.88%16.6M | -15.97%17.01M | -23.01%18.86M | 23.91%19.75M |
| Lease liabilities | 14.37%111M | 10.38%108.95M | 10.51%114.5M | -1.39%107.29M | -11.90%97.05M | -6.20%98.71M | 18.41%103.61M | 25.53%108.8M | -1.30%110.16M | -8.66%105.23M |
| Other non current liabilities | -5.30%37.11M | -22.25%37.76M | -17.02%38.91M | -18.94%39.35M | 26.57%39.18M | 80.78%48.57M | 56.58%46.89M | 47.63%48.54M | -1.46%30.96M | -23.32%26.87M |
| Total non current liabilities | 5.78%289.49M | 2.44%275.09M | 7.83%290.14M | 2.63%276.81M | 28.58%273.68M | 26.03%268.53M | 26.93%269.07M | 9.40%269.72M | -13.25%212.85M | -11.39%213.07M |
| Total liabilities | 33.50%3.39B | -13.49%2.8B | 39.06%3.39B | 13.67%3.16B | 18.87%2.54B | 13.27%3.24B | 16.29%2.44B | 16.63%2.78B | -2.27%2.13B | 39.25%2.86B |
| Shareholders equity | ||||||||||
| Paid-in capital | 0.00%603.32M | 0.00%603.32M | 0.00%603.32M | 0.00%603.32M | 0.00%603.32M | 0.00%603.32M | 0.00%603.32M | 0.00%603.32M | 0.00%603.32M | 0.00%603.32M |
| Capital reserve funds | 0.07%1.1B | 0.07%1.1B | 0.08%1.09B | 0.09%1.09B | -0.12%1.09B | -0.12%1.09B | 0.73%1.09B | 0.72%1.09B | 0.90%1.1B | 0.89%1.1B |
| Surplus reserve funds | 18.68%1.61B | 18.68%1.61B | 18.68%1.61B | 18.68%1.61B | 21.17%1.35B | 21.17%1.35B | 21.17%1.35B | 21.17%1.35B | 26.17%1.12B | 26.17%1.12B |
| Retained profit | 7.44%10.59B | 14.74%10.32B | 22.23%10.97B | 21.82%10B | 22.87%9.86B | 23.46%8.99B | 21.48%8.98B | 22.48%8.21B | 22.21%8.02B | 28.51%7.28B |
| Other composite income | 27.31%127.68M | -45.28%47.3M | -32.18%58.85M | 2.95%76.6M | 67.64%100.29M | -29.02%86.45M | -36.49%86.77M | -62.81%74.41M | -70.99%59.83M | -41.03%121.8M |
| Shareholders equity without minority interests | 7.80%14.02B | 12.70%13.67B | 18.34%14.33B | 18.06%13.38B | 19.36%13.01B | 18.67%12.13B | 17.24%12.11B | 16.74%11.33B | 16.62%10.9B | 20.98%10.22B |
| Minority interests | 5.12%580.2M | 6.84%575.29M | 10.30%572.94M | 10.16%544.17M | 14.34%551.92M | 15.94%538.44M | 16.11%519.44M | 14.33%493.97M | 7.17%482.71M | 6.47%464.4M |
| Total shareholder equity | 7.69%14.6B | 12.45%14.24B | 18.01%14.91B | 17.73%13.92B | 19.15%13.56B | 18.55%12.67B | 17.19%12.63B | 16.64%11.82B | 16.18%11.38B | 20.27%10.69B |
| Total liabilityies and equity | 11.75%17.99B | 7.17%17.05B | 21.41%18.29B | 16.96%17.08B | 19.10%16.1B | 17.44%15.91B | 17.05%15.07B | 16.63%14.6B | 12.82%13.51B | 23.83%13.55B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Huaxing Certified Public Accountants Firm (Special General Partnership) | -- | -- | -- | Huaxing Certified Public Accountants Firm (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
